TrianglePUBLICATIONS · 27418251
Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- BMC Cancer
- Publication date
- 2016 Jul 14
- First author
- Morioka H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Morioka H
- type
- Author
- name
- Takahashi S
- type
- Author
- name
- Araki N
- type
- Author
- name
- Sugiura H
- type
- Author
- name
- Ueda T
- type
- Author
- name
- Takahashi M
- type
- Author
- name
- Yonemoto T
- type
- Author
- name
- Hiraga H
- type
- Author
- name
- Hiruma T
- type
- Author
- name
- Kunisada T
- type
- Author
- name
- Matsumine A
- type
- Author
- name
- Susa M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Morioka H
- type
- Author
- name
- Takahashi S
- type
- Author
- name
- Araki N
- type
- Author
- name
- Sugiura H
- type
- Author
- name
- Ueda T
- type
- Author
- name
- Takahashi M
- type
- Author
- name
- Yonemoto T
- type
- Author
- name
- Hiraga H
- type
- Author
- name
- Hiruma T
- type
- Author
- name
- Kunisada T
- type
- Author
- name
- Matsumine A
- type
- Author
- name
- Susa M
- type
- Author
- bibliography ids
- nci-bib-33d33a905626424cc48a5c1a
- book metadata
- content sha256
- 0f10bbce142464b949e791f247e3d64e61914dc16657066df06a34c2d79754a8
- document type
- citation
- dois
- 10.1186/s12885-016-2511-y
- electronic publication date
- display
- 2016 Jul 14
- precision
- day
- year
- 2016
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:27418251
- immutable id
- pubmed:27418251@0f10bbce142464b949e791f247e3d64e61914dc16657066df06a34c2d79754a8
- journal
- abbreviation
- BMC Cancer
- issn electronic
- 1471-2407
- issn print
- Source null
- issue
- Source null
- name
- BMC cancer
- nlm unique id
- 100967800
- pages
- 479
- volume
- 16
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 27418251
- provenance
- batch id
- d649bcb2d98dbbacd53c
- provider
- NCBI PubMed ESummary
- record sha256
- 791155f5dcfc118920dc17311cd026a1fcc646d2865523b39091f0e1b647e79f
- response sha256
- 26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
- retrieved at
- 2026-09-09T23:47:20.761544+00:00
- publication date
- display
- 2016 Jul 14
- precision
- day
- year
- 2016
- publication types
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.
Preserved source evidence · Not medical advice